Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.007x

Based on the latest financial reports, Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) has a cash flow conversion efficiency ratio of 0.007x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs8.20 Million ≈ $88.66K USD) by net assets (Rs1.19 Billion ≈ $12.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Aarey Drugs & Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Aarey Drugs & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read AAREYDRUGS total liabilities for a breakdown of total debt and financial obligations.

Aarey Drugs & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aarey Drugs & Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Timberwell Bhd KLSE:7854	0.017x
Malmbergs Elektriska AB (publ) ST:MEAB-B	-0.016x
Tien Wah Press Holdings Bhd KLSE:7374	0.095x
MegaMD Co. Ltd KQ:133750	-0.005x
Optrontec Inc KQ:082210	-0.058x
Nova Agritech Ltd. NSE:NOVAAGRI	0.003x
Simat Technologies Public Company Limited BK:SIMAT	-0.062x
Halloren Schokoladenfabrik Aktiengesellschaft HM:H2RB	N/A

Annual Cash Flow Conversion Efficiency for Aarey Drugs & Pharmaceuticals Limited (2009–2025)

The table below shows the annual cash flow conversion efficiency of Aarey Drugs & Pharmaceuticals Limited from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see AAREYDRUGS market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs1.38 Billion ≈ $14.98 Million	Rs8.95 Million ≈ $96.77K	0.006x	+128.66%
2024-03-31	Rs1.33 Billion ≈ $14.36 Million	Rs-29.94 Million ≈ $-323.77K	-0.023x	-106.66%
2023-03-31	Rs1.17 Billion ≈ $12.70 Million	Rs-12.81 Million ≈ $-138.55K	-0.011x	+72.40%
2022-03-31	Rs1.14 Billion ≈ $12.29 Million	Rs-44.93 Million ≈ $-485.90K	-0.040x	-171.37%
2021-03-31	Rs988.60 Million ≈ $10.69 Million	Rs54.77 Million ≈ $592.32K	0.055x	+79.06%
2020-03-31	Rs923.46 Million ≈ $9.99 Million	Rs28.57 Million ≈ $309.00K	0.031x	+288.83%
2019-03-31	Rs865.53 Million ≈ $9.36 Million	Rs6.89 Million ≈ $74.48K	0.008x	+103.14%
2018-03-31	Rs802.45 Million ≈ $8.68 Million	Rs-203.51 Million ≈ $-2.20 Million	-0.254x	-1427.42%
2017-03-31	Rs503.60 Million ≈ $5.45 Million	Rs9.62 Million ≈ $104.05K	0.019x	-87.61%
2016-03-31	Rs366.97 Million ≈ $3.97 Million	Rs56.59 Million ≈ $612.01K	0.154x	+67.84%
2015-03-31	Rs354.09 Million ≈ $3.83 Million	Rs32.53 Million ≈ $351.84K	0.092x	+851.96%
2014-03-31	Rs345.21 Million ≈ $3.73 Million	Rs-4.22 Million ≈ $-45.62K	-0.012x	-112.13%
2013-03-31	Rs334.70 Million ≈ $3.62 Million	Rs33.72 Million ≈ $364.71K	0.101x	+136.83%
2012-03-31	Rs328.12 Million ≈ $3.55 Million	Rs-89.76 Million ≈ $-970.74K	-0.274x	+39.84%
2011-03-31	Rs219.05 Million ≈ $2.37 Million	Rs-99.61 Million ≈ $-1.08 Million	-0.455x	-254.49%
2010-03-31	Rs92.08 Million ≈ $995.81K	Rs-11.81 Million ≈ $-127.73K	-0.128x	-3666.00%
2009-03-31	Rs83.97 Million ≈ $908.15K	Rs302.06K ≈ $3.27K	0.004x	--

About Aarey Drugs & Pharmaceuticals Limited

NSE:AAREYDRUGS India Drug Manufacturers - Specialty & Generic

Market Cap

$27.93 Million

Rs2.58 Billion INR

Market Cap Rank

#23936 Global

#1323 in India

Share Price

Rs91.08

Change (1 day)

+0.63%

52-Week Range

Rs50.16 - Rs99.25

All Time High

Rs99.25